Source is heading to ISPOR Europe 2026 in Vienna

Sep 7, 2026 | News & Events

Source Health Economics will be at ISPOR Europe 2026, taking place from 8 to 11 November at the Austria Center, Vienna.

You’ll find our team at booth #928 throughout the event.

What we’ll be discussing at the booth: 

Our team will be on hand to talk about the work we do day-to-day, including: 

  • Commercialisation and pricing strategy
  • Health economic modelling
  • Health technology assessment (HTA) submissions
  • Systematic literature reviews and indirect treatment comparisons 
  • Value communication. 

Come and say hello 

Vienna in November is a good excuse for a coffee and a proper conversation about the challenges you’re working through.

Why we’re there 

ISPOR Europe is the largest annual gathering for health economics and outcomes research in Europe, and one of the few places where HEOR specialists, payers and life sciences teams are all in the same room at the same time.

For us, it’s a chance to catch up with existing clients, meet people working on problems we can help solve, and hear what’s shaping HEOR strategy across the industry.

We’d love to see you in Vienna at booth #928!
ISPOR booth #928
Source is attending ISPOR 2026

More Insights

HTA update – September 2026

HTA update – September 2026

Written by Louis Barwell   September was a month in which health technology assessment (HTA) policy and ...
Partitioned survival, Markov, or patient-level simulation modelling?

Partitioned survival, Markov, or patient-level simulation modelling?

Partitioned survival, Markov, or patient-level simulation? A look at the trade-offs between model structures used in health economic evaluations, and how to choose the right one for your decision problem.
Introducing the Value Equation Podcast

Introducing the Value Equation Podcast

Hosted by Manda Li, our Pricing and Commercialisation Analyst, the series brings specialists from across SCIRIS Group's agencies into one conversation about the decisions that determine whether a strong medicine becomes a successful one.
No results found.